clinical trial · NCT06988670
A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
HypoparathyroidismEXT608Placebo
brief summary
The goal of this clinical trial is to investigate the safety, tolerability and efficacy of EXT608 in adults with hypoparathyroidism.
started
May 5, 2025
primary completion
May 1, 2027
completion
May 1, 2027
last updated
May 25, 2025
official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol